Raising the bar: A plea for standardization and quality improvement in the practice of breast pathology

Breast Journal

Volumn 12, Issue 5, 2006, Pages 409-412

  Masood, Shahla ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ERROR; EDITORIAL; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; IMMUNOCYTOCHEMISTRY; MAMMOGRAPHY; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; PATIENT CARE; PRACTICE GUIDELINE; SENTINEL LYMPH NODE BIOPSY; TREATMENT FAILURE;

BREAST NEOPLASMS; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; PATHOLOGY, CLINICAL; QUALITY CONTROL; REFERENCE STANDARDS; UNITED STATES;

EID: 33748370983     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00337.x     Document Type: Editorial

References (24)

1. Collins LC, Connelly JL, Page DL, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol 2004;28:126-131.
2. Demartines N, Mutter D, Vix M, et al. Assessment of telemedicine in surgical education and patient care. Ann Surg 2000;231:282-291.
3. Fitzgibbons PL. Atypical lobular hyperplasia of the breast - a study of pathologists' responses in the College of American Pathologists Performance Improvement Program in surgical pathology. Arch Pathol Lab Med 2000;124:463-464.
4. Guinebretiere JM, Becette V, Hagay C, et al. Use of radiology for the pathologists in the management of breast lesions. Eur J Radiol 2005;54:15-25.
5. Imperato PJ, Waisman J, Wallen MD, et al. Improvements in breast cancer pathology practices among Medicare patients undergoing unilateral extended simple mastectomy. Am J Med Quality 2003;18:164-170.
6. Masood S. A plea for standardization of biomarker assays in the study of high risk, premalignant and malignant breast disease. The Breast Journal 1995;1(4):199-201.
7. Masood S. Standard guidelines for breast fine-needle aspiration biopsy: A new challenge. The Breast Journal 1996;2(4)231-232.
8. Masood S. Standardization of immunobioassays as surrogate end points. Journal of Cellular Biochemistry Supplement 1994;19:28-35.
9. Masood S. Why a new society? A call for action: advancing knowledge in breast pathology. The Breast Journal 2003;9(4):263-265.
10. Nakhleh RE, Jones B, Zarbo RJ. Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions. Arch Pathol Lab Med 1997;121:11-18.
11. Paik S, Bryant J, Tan-Chiu E, et al. Real-World Performance of HER2 Testing - National Surgical Adjuvant Breast and Bowel Project Experience. J Natl Cancer Inst 2002;94:852-854.
12. Raab SS, Grzybicki DM, Janosky JE, et al. Clinical impact and frequence of anatomic pathology errors in cancer diagnoses. Cancer 2005;104:2205-2213.
13. Rhodes A, Jasani B, Barnes DM, et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 2000;53:125-130.
14. Roche PC, Suman VJ, Jenkins RB, et al. Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831. J Natl Cancer Inst 2002;94:855-857.
15. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991;15:209-221.
16. Schnitt SJ, Connolly JL, Tavassoli FA, et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992;16:1133-1143.
17. Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosis. Diagnostic Cytopathology 1993;9(6):713-728.
18. Silverstein MJ, Lagios MD, Recht A, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 2005;201:586-597.
19. Staradub VL, Messenger KA, Hao N, et al. Changes in breast cancer therapy because of pathology second opinions. Ann Surg Oncol 2002;9:982-987.
20. Torres MI, Webster FB, Bilous AM, et al. Supporting the implementation of breast pathology recommendations: feasibility of a feedback mechanism to pathologists. Pathology 2003;35:402-408.
21. Tot T, Tabar L, Dean PB. The pressing need for better histologic-mammographic correlation of the many variations in normal breast anatomy. Virchows Arch 2000;437:338-344.
22. Velan GM, Kumar RK, Dziegielewski M, Wakefield D. Web-based self-assessments in pathology with Question Mark Perception. Pathology 2002;34:282-284.
23. Wells WA, Carney PA, Eliassen MS, et al. Statewide study of diagnostic agreement in breast pathology. J Natl Cancer Inst 1998;90:142-145.
24. Wilkinson NW, Shahryarinejad A, Winston JS, et al. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg 2003;196:38-43.